NCT01034462[Secondary Source ID] - Search Results

Your saved search

Your RSS Feed

Year	Number of Results
2014	1
2015	1
2017	1
2025	0

Page 1

A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder.

Sambunaris A, Bose A, Gommoll CP, Chen C, Greenberg WM, Sheehan DV. Sambunaris A, et al. J Clin Psychopharmacol. 2014 Feb;34(1):47-56. doi: 10.1097/JCP.0000000000000060. J Clin Psychopharmacol. 2014. PMID: 24172209 Free PMC article. Clinical Trial.

Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study.

Wesnes KA, Gommoll C, Chen C, Sambunaris A, McIntyre RS, Harvey PD. Wesnes KA, et al. Int Clin Psychopharmacol. 2017 Mar;32(2):72-79. doi: 10.1097/YIC.0000000000000157. Int Clin Psychopharmacol. 2017. PMID: 27861191 Free PMC article. Clinical Trial.

Levomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.

Cutler AJ, Gommoll CP, Chen C, Greenberg WM, Ruth A. Cutler AJ, et al. Prim Care Companion CNS Disord. 2015 Jun 11;17(3):10.4088/PCC.14m01753. doi: 10.4088/PCC.14m01753. eCollection 2015. Prim Care Companion CNS Disord. 2015. PMID: 26644957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year